Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.36 |
| ▸ | PRKCG | P05129 | 2/20 | 0.36 |
| ▸ | PRKCB | P05771 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.36 |
| ▸ | PRKACA | P17612 | 2/20 | 0.36 |
| ▸ | PRKACG | P22612 | 2/20 | 0.36 |
| ▸ | PRKACB | P22694 | 2/20 | 0.36 |
| ▸ | PRKCH | P24723 | 2/20 | 0.36 |
| ▸ | PRKCI | P41743 | 2/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.36 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10135627 | 0.89 | CYP19A1 (0.46) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135624 | 0.87 | ROCK1 (0.46) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135637 | 0.87 | ROCK1 (0.46) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135797 | 0.87 | CYP19A1 (0.44) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135677 | 0.86 | ROCK1 (0.45) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135701 | 0.85 | ROCK1 (0.44) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135734 | 0.85 | ROCK1 (0.44) | CYP19A1PRKCZROCK1TBXAS1CYP3A4 | |
| SCHEMBL10135646 | 0.79 | CYP19A1 (0.45) | CYP19A1PRKCZROCK1TBXAS1CHRM2 | |
| SCHEMBL10135728 | 0.79 | CYP19A1 (0.45) | CYP19A1PRKCZROCK1TBXAS1CHRM2 | |
| SCHEMBL10135742 | 0.79 | CYP19A1 (0.45) | CYP19A1PRKCZROCK1TBXAS1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951997-B2 | Substituted isoquinoline derivative | D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) | 2015-02-10 | — | — | US | disclosed |
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | SULT1A1, SULT1E1, SULT2A1 | CYP19A1 2996/4885PRKCZ 3050/4885ROCK1 1837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.